Nicole Murphy - Apr 1, 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Wendell Taylor, attorney in fact for Nicole Murphy
Stock symbol
BIIB
Transactions as of
Apr 1, 2022
Transactions value $
-$17,695
Form type
4
Date filed
4/5/2022, 05:44 PM
Previous filing
Feb 23, 2022
Next filing
Aug 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise +239 +14.42% 1.9K Apr 1, 2022 Direct F1
transaction BIIB Common Stock Tax liability -$17.7K -84 -4.43% $210.65 1.81K Apr 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise -239 -33.29% 479 Apr 1, 2022 Common Stock 239 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit is converted to one share of common stock upon vesting.
F2 This award was granted to the reporting person on April 1, 2021 and vested with respect to 239 shares on April 1, 2022. The remaining portion of the award vests in equal installments on each of the second and third anniversary of the grant date.